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ARTICLE IN PRESSAbstractInnate, inﬂammatory responses towards persistent Opisthorchis viverrini (OV) infection
are likely to contribute to the development of cholangiocarcinoma (CCA), a liver cancer
that is rare in the West but prevalent in Greater Mekong Subregion countries in South-
east Asia. Infection results in the inﬁltration of innate immune cells into the bile ducts
and subsequent activation of inﬂammatory immune responses that fail to clear OV but
instead may damage local tissues within the bile ducts. Not all patients infected with
OV develop CCA, and so tumourigenesis may be dependent on multiple factors
including the magnitude of the inﬂammatory response that is activated in infected
individuals. The purpose of this review is to summarize how innate immune responses
may promote tumourigenesis following OV infection and if such responses can be used
to predict CCA onset in OV-infected individuals. It also hypothesizes on the role that
Helicobacterspp., which are associated with liver ﬂuke infections, may play in activation
of the innate the immune system to promote tissue damage and persistent inﬂamma-
tion leading to CCA.1. INTRODUCTION
1.1 Opisthorchis viverrini, An Endemic Disease
Throughout Southeast AsiaInfection with the liver ﬂukeOpisthorchis viverrini (OV), or opisthorch-
iasis, has long been linked with the onset of cholangiocarcinoma (CCA).
The parasite infects human hosts (and other piscivorous animals) when
they eat OV-infected, undercooked/raw cyprinoid ﬁsh. Rates of OV infec-
tion are especially high in the northeastern region of Thailand (Sithithaworn
et al., 2012a; Yeoh et al., 2015), where persistent infection is a consequence
of eating raw ﬁsh, often as part of traditional dishes such as ‘Koi Pla’ and ‘Pla
Som’. Numerous control programmes have been implemented in OV
endemic areas (Sripa et al., 2015), but despite initial decreases in opisthorch-
iasis following the introduction of such programmes, rates of CCA remain
high in Thailand and neighbouring countries, such as Lao-PDR, Cambodia
and Vietnam. This disease therefore continues to place a severe burden on
both the health services and the regional economy (Andrews et al., 2008),
highlighting an urgent need for an improved understanding of OV patho-
genesis and of the processes that lead to the development of CCA. OV
infection and liver disease are often asymptomatic, and there is currently
no cure for CCA, and often metastasis has occurred before detection,
with patients surviving for only short periods (sometimes less than 4 months)
post diagnosis (Luvira et al., 2016). To date, the antihelminthic drug
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infection, and not CCA itself.
There is considerable heterogeneity in pathological outcomes following
OV infection, with some individuals infected for their entire lives without
showing any clinical symptoms. However, approximately 25% of those
infected with OV develop advanced periductal ﬁbrosis and approximately
1% develop CCA (Mairiang et al., 2012). The reasons for this disease hetero-
geneity are not fully understood, but it has been hypothesized that a ‘proin-
ﬂammatory phenotype’ predisposes particular individuals to develop
advanced periductal ﬁbrosis (APF) following OV infection that may lead
to CCA (Sripa et al., 2012a). If it is the case that OV-induced CCA is related
to patient-speciﬁc immune responses, then identifying these responses may
make the onset of cancer more predictable or perhaps preventable. To date,
whilst many reviews have suggested a possible link between OV-induced
CCA and adaptive inﬂammatory responses, there is a paucity of literature
describing speciﬁc innate immune cell responses to OV. If the nature of
the nonspeciﬁc, innate immune responses towards OV can be identiﬁed
and are conﬁrmed to be responsible for causing or contributing to the devel-
opment of CCA, these may represent novel targets for treatment and pre-
vention of OV-induced CCA (Sripa et al., 2012a). In addition, these
responses may serve as biomarkers that could identify individuals at risk of
developing CCA following OV infection and hence enable a more targeted
approach to prevention and therapy. This review aims to improve our
understanding of the innate immune responses elicited by OV infection
and discusses how this may be linked to the onset of CCA. It highlights a
possible link between liver ﬂuke infection, Helicobacter coinfection and
innate immune cell activation in disease pathology.
1.2 Opisthorchis viverrini: An Infectious Agent Capable of
Driving Cancer
Infection with OV can cause jaundice, cholangitis and CCA, which is a
malignancy of the bile duct epithelium, and relatively rare worldwide but
highly prevalent in Mekong countries (Sithithaworn et al., 2012b). CCA
is usually associated with OV infection, but alcohol, smoking and diets con-
taining nitrogenous compounds may all contribute towards malignancy
(Sithithaworn et al., 2014). There are two recognized types of CCA, OV-as-
sociated and non-OV-associated, which have differential carcinoma expres-
sion proﬁles, but the 5-year survival rate for both pathologies is <5%
(Sripa and Pairojkul, 2008; Ghouri et al., 2015). The initiation of CCA in
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ating epithelial cells that may have an increased risk of tumourigenesis when
also exposed to carcinogens (Sripa et al., 2007). Due to its association with
CCA, OV is recognized as a Group 1 carcinogen and one of few infections
that have known carcinogenic properties; others include Hepatitis B and
Helicobacter pylori infections (IARC, 2011). Other liver ﬂukes endemic in
Southeast Asia, including Clonorchis sinensis and Opisthorchis felineus
(Lim, 2011), are less frequently associated with CCA.
There are three hypothesized causes of OV-induced CCA: (1) chronic or
persistent inﬂammatory responses towards persistent opisthorchiasis; (2) anti-
apoptotic/immunomodulatory properties ofO. viverrini excretory/secretory
(OVES) products products; and (3) structural damage caused by OV feeding
on epithelial cells (Sripa et al., 2007; Sripa et al., 2012a). All three processes
may be involved and may contribute to CCA. Inﬂammatory responses,
particularly those that result in the generation of free radicals, may inﬂict
oxidative and nitrogenous damage on the DNA of local cells, a well-
established hallmark of cancer (Murata et al., 2012; Yongvanit et al.,
2012a). The recent discovery of an association between OV infection
with Helicobacter infections (H. pylori and H. bilis) (Deenonpoe et al.,
2015, 2017) and the known effects of these bacteria in both cancer patho-
genesis and immune cell activation suggest an additional mechanism to
explain how inﬂammation may contribute to the development of CCA
(Sripa et al., 2017).
The fact that opisthorchiasis is in decline in some regions, but CCA re-
mains prevalent, suggests that either OV infection alone cannot directly
induce CCA, and that a multitude of factors are involved in CCA pathogen-
esis, or alternatively, that OV infection is an initiator of cancer. Thus, if tissue
damage is initiated by OV-induced inﬂammation, then a vicious cycle of
inﬂammationdtissue damage: inﬂammation leading to CCAdmay exist
even when the OV infection has been cleared by treatment (Fig. 1). This
concept is supported in hamster models, where CCA only develops when
OV infection is combined with exposure to subcarcinogenic dose of nitro-
samines such as N-nitrosodimethylamine (NDMA) (Thamavit et al., 1978;
Boonmars et al., 2011). Nitrosamines from fermented ﬁsh are common in
the diet of those who eat traditional, raw ﬁsh meals and are also linked
with carcinogenesis (Bartsch and Montesano, 1984). Infection with OV
alone causes hamsters to develop intrahepatic and extrahepatic biliary dam-
age/abnormalities associated with CCA (Thamavit et al., 1978), but not the
onset of cancer itself. It would appear that infected hosts cannot produce an
Figure 1 Proposed role of persistent inﬂammation in the development of cholan-
giocarcinoma following infection with the liver ﬂuke, Opisthorchis viverrini (O. viver-
rini). In (A), infection with the liver ﬂuke leads to inﬂammation that can (along with
other factors, see Fig. 2) result in the development of ﬁbrosis and subsequently
cholangiocarcinoma. In (B), it is proposed that, in some individuals, inﬂammation
can persist even after the parasite has been cleared (e.g., by praziquantel treat-
ment). This persistent inﬂammation may lead to a vicious cycle of inﬂammation/
damage that can lead to ﬁbrosis and ultimately cholangiocarcinoma. In this pro-
posed model, inﬂammation can drive liver ﬁbrosis, whereas liver ﬁbrosis can also
drive further cycles of inﬂammation.
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of evading or modulating immune responses, which allows its survival
(McSorley et al., 2013). The persistent inﬂammatory responses directed
towards OV indirectly promote tumourigenesis by providing the suitable
microenvironment for tumours to develop but may require additional
carcinogens such as nitrosamines and alcohol, to initiate tumourigenesis (Sripa
et al., 2007, Fig. 2). It is feasible that OV infection physically blocks the bile
ducts, with the result that the accumulated endogenous nitrosamines and free
radicals have prolonged exposure to local cells and attain very high local con-
centrations, increasing the chances of DNA damage (Sripa et al., 2007).
The hypothesized ‘proinﬂammatory phenotype’ may only reveal itself in
instances of long-term or repeated infections, such as during OV infection or
untreated Helicobacter infections, and this unresolved and sustained inﬂam-
mation may lead to tissue damage and initiation of carcinogenesis and
CCA (Sripa et al., 2012a, 2017). There have been several reviews that discuss
the link between inﬂammatory responses and cancer, which may also be
applicable to OV-induced CCA (Grivennikov et al., 2010; Balkwill and
Figure 2 Proposed interplay between parasites, Helicobacter and inﬂammation in the
events that lead to periductal ﬁbrosis, DNAmutations, hyperplasia and malignant trans-
formations that can lead to the development of cholangiocarcinoma. Modiﬁed from
Sripa, B., Deenonpoe, R., Brindley, P.J., 2017. Coinfections with liver ﬂuke and Helicobacter
species: a paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma?
Parasitol. Int. 66, 383e389.
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drawn with H. pylori infection, where almost 50% of the world’s population
are infected, yet only some develop the associated gastric cancer. Opis-
thorchiasis therefore represents another example of an inﬂammatory disease
that elevates the possibility of cancer and may have some parallels with
diseases such as rheumatoid arthritis and atherosclerosis (Chen et al., 2011;
Pittet and Swirski, 2011).
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2.1 Regulation of Immune Cell Activation During
Helminth InfectionsInﬂammation in the context of helminth infection differs from other
classical acute, inﬂammatory responses because helminths possess immuno-
modulatory properties. Helminths are capable of regulating the normal T
helper 2 (Th2) responses against pathogens, mediated by immunoglobulin
(Ig)E, eosinophils, mast cells and Th2 cytokines such as interleukin (IL)-4
and IL-5 (Maizels and Yazdanbakhsh, 2003; Maizels et al., 2014). Unlike
microbial pathogen recognition, there are no clearly identiﬁed pathogen-
associated molecular patterns on helminths that facilitate their recognition
by pattern recognition receptors (PRRs) on immune cells (Perrigoue
et al., 2008). Helminth-mediated immunomodulation is typically associated
with increased antiinﬂammatory mediators such as IL-10 levels and Treg
activity, a ﬁnding validated in mouse models (Wilson et al., 2005). Hel-
minths modulate host immunity via induction of strong Th2 responses,
while downregulation of type 1 inﬂammation modifying the intestinal envi-
ronment to promote their survival (Maizels et al., 2004). High expression
levels of OV defence proteins, including T265_13308, in the bile duct
may be responsible for immunomodulation to enable continued parasite
feeding (Sithithaworn et al., 2014). The resulting immunomodulation is
thought to promote helminth survival within human hosts (Suttiprapa
et al., 2008).
The inﬁltration of inﬂammatory cells to sites of infection and ﬁbrotic tis-
sue/tumours is a consistent observation in hamster models (Sripa and
Kaewkes, 2000, 2002). The inﬁltration of immune cells to sites of OV infec-
tion suggests that OVES products may either directly or indirectly (via inﬂu-
encing host cells) generate chemoattractant molecules. Neutrophils are
recruited to the infected bile ducts in the early stages of infection, followed
by eosinophils and monocytes which then predominate (Bhamarapravati
et al., 1978; Jittimanee et al., 2007; Wongratanacheewin et al., 2003).
Damage-associated molecular pattern signalling from necrotic cells damaged
by OV feeding may also stimulate the recruitment of inﬂammatory immune
cells (Kono and Rock, 2008). Much research has focussed on identifying the
extracellular vesicles and soluble secreted molecules from OV in culture
(OVES products) (Chaiyadet et al., 2015b, 2017). An OVES product has
been hypothesized to sequester signals from necrotic cells, allowing the
8 Steven W. Edwards et al.
ARTICLE IN PRESSparasite to feed and possibly evade detection (Smout et al., 2009). This may
be an example of immunomodulatory properties of OV (Wongratanachee-
win et al., 1987), masking wound damage in an attempt to decrease acute
immune responses. It is established that T cells are not required for the
recruitment and inﬁltration of innate immune cells (Flavell and Flavell,
1986) but may mediate inﬂammatory responses within the biliary network
during opisthorchiasis.
The inﬁltration and recruitment of inﬂammatory cells to the site of infec-
tion is likely to be inﬂuenced by soluble OVES molecules eliciting IL-6 and
IL-8 release from cholangiocytes. These cytokines are released following
Toll-like receptor (TLR)-4-mediated activation of nuclear factor kappa-
light-chain enhancer of activated B cells (NF-kB) via myeloid differentiation
primary response gene 88 (MyD88) (Ninlawan et al., 2010). It is likely that
the production of chemoattractant (IL-8) chemokines and proinﬂammatory
(IL-6) cytokines from these nonimmune cell cholangiocytes is driven by cla-
thyrin-mediated endocytosis of vesicular OVES products (Chaiyadet et al.,
2015a). Notably, these chemokines and cytokines released during OV infec-
tion ( Jittimanee et al., 2007) are also likely to stimulate the inﬂux of immune
cells to the infection site, which then themselves generate chemoattractants.
It would also be of interest to deﬁne how the complement cascade responds
to OV, given that the cascade is crucial to alerting innate cells to infection
and can generate its own immune cell chemoattractants, such as C5a or C3a.
2.2 Immune Cell Responses to OV/OVES Products
It is somewhat surprising that literature covering speciﬁc responses of innate
inﬂammatory cells towards OV is rather limited, given that inﬁltration of
these cells to the site of infection is a consistent observation in animal models
of OV infection. Eosinophilia is associated with OV infection (Nishiura
et al., 2003) and is common in other parasitic infections (Shin et al.,
2009). In the case of OV, there is early inﬁltration of neutrophils and
both eosinophils and macrophages are persistently abundant around the
site of infections after several weeks and months (Bhamarapravati et al.,
1978; Sripa and Kaewkes, 2000). Therefore, it would be important to deter-
mine the speciﬁc responses of eosinophils and macrophages to OV/OVES
products. This may reveal if innate responses are regulated directly by
OV/OVES products and whether such a mechanism could explain the
inﬂammatory damage observed in opisthorchiasis.
We have made the recent and novel discovery that circulating blood
neutrophils fromOV-infected individuals have a greater capacity to produce
Opisthorchiasis-Induced Cholangiocarcinoma: How Innate Immunity May Cause Cancer 9
ARTICLE IN PRESSreactive oxygen metabolites ROS (reactive oxygen species) and undergo
phagocytosis than healthy controls (unpublished observations). These circu-
lating neutrophils also have elevated surface expression of the integrin,
CD11b. Moreover, neutrophils from OV-infected individuals with
advanced periductal ﬁbrosis have an even greater capacity to generate
ROS and phagocytose and are sensitized to the stimulatory effects of
OVES. This previously unrecognized involvement of circulating neutro-
phils during OV infection, particularly in those with liver disease, indicates
a systemic activation of the innate immune system and a role for these cells in
the pathological events associated with persistent inﬂammation.
Recently, signiﬁcant increases in a number of proinﬂammatory and
antiinﬂammatory cytokines were measured in isolated peripheral blood
mononuclear cells (PBMCs) of non-OV-infected and OV-infected, CCA-
positive patients stimulated with OVES products in vitro (Hongsrichan
et al., 2014; Surapaitoon et al., 2017). Although it was not clear which cells
were responsible for the cytokine release, i.e., T or B lymphocytes, mono-
cytes or neutrophils, this research demonstrated that cytokine release from
both unstimulated and stimulated PBMCs of OV-induced CCA patients
was signiﬁcantly elevated above levels in uninfected individuals. Whilst
observations that individuals may acquire successive, repeated infections
suggest inefﬁcient innate and humoral responses that fail to clear OV (Flavell
et al., 1980), this PBMC response to OV suggests a persistently activated
state, increased sensitivity and perhaps even memory for responses to OV/
OVES products. This may provide evidence of PBMCs from CCA patients
becoming more responsive or ‘primed’ to OVES products, developing a
form of memory that allows for a more rapid and greater release of cyto-
kines. This ‘prepared’ state of PBMCs to release cytokines may regulate
increased inﬂammatory responses to repeated infection and/or further
release of OVES products, and it would be of great interest to determine
if this ‘primed’ state also occurs in other immune cells. Alternatively, altered
responses of PBMCs in CCA patients may be in response to the cancer. In
the case of persistent infection, the upregulation of these cytokines (and
perhaps other yet unidentiﬁed cytokines) will likely recruit immune cells
and promote inﬂammatory responses in response to OV infection. It is
therefore important to fully characterize these immune responses, including
cytokine proﬁling, in other immune cells that are activated in OV infection,
such as neutrophils and monocytes.
In the RAW264 macrophage-like cell line, OV antigen activates
NF-kB-induced upregulation of inducible nitric oxide synthase (iNOS)
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was comparable to responses of human peripheral blood leukocytes (PBLs),
which also upregulated COX-2 and manganese superoxide dismutase 2
(MnSOD-2) and downregulated catalase (CAT) (Yongvanit et al.,
2012a,b). However, it should be noted that this report did not specify which
immune cells in the PBL population responded to OV antigen but does sug-
gest that immune cells that possess TLR-2 receptors may be activated by OV
antigen. Understanding which TLRs can be activated by OV will enhance
our understanding of OV and provide insights into the biochemical compo-
sition of the parasite/antigen/OVES products and how comparable it is to
that of other helminths/pathogens. Interestingly, while TLR-4 expression
was not upregulated in the RAW264 cell line, it was signiﬁcantly upregu-
lated in cholangiocytes which could be responsible for enhanced IL-6 and
IL-8 expression (Ninlawan et al., 2010). In addition, the upregulation of
COX-2 suggests increased production of prostaglandins that may assist im-
mune cell inﬁltration by stimulating processes such as vasodilation.
Both inﬁltrating and tissue-resident macrophages respond to OV
(Pinlaor et al., 2009). However, the upregulation of iNOS in the
RAW264 macrophage cell line is somewhat surprising, given that the anti-
inﬂammatory and proliferative M2 phenotype of macrophages has been
observed after chronic OV infection (Bility and Sripa, 2014; Thanee
et al., 2015); this may represent differences in functions between RAW264 -
cells and human macrophages. This M2 phenotype is associated with assist-
ing wound healing processes which may be linked to ﬁbrosis in chronic
infections and promoted by the predominant Th2 response in OV-infected
hamsters ( Jittimanee et al., 2007). The M2 phenotype is not normally asso-
ciated with proinﬂammatory characteristics, nor the inﬂammatory damage
observed in opisthorchiasis. These latter phenotypes are more typical char-
acteristics of the proinﬂammatory M1 phenotype. It would be of interest to
determine if OV/OVES products generated at different stages of infection
promote different subsets of each macrophage phenotype. Certainly, more
research is required on this topic, as the concept of macrophage polarization
in disease is still not well understood and requires further understanding.
2.3 OV-Induced Oxidative/Nitrative Damage and Survival of
Parasites
The production of ROS/reactive nitrogen species (RNS) during a ‘respira-
tory burst’ is a key characteristic of inﬂammatory responses of cells such as
neutrophils and macrophages during infection (Wright et al., 2010). The
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8-oxo-7,8-dihydro-20-deoxyguanosine (8-oxodG) lesions observed in the
bile ducts of hamsters with repeated OV infection may be associated with
immune cell iNOS production of nitric oxide (NO) (MacMicking et al.,
1997; Pinlaor et al., 2004). These DNA lesions may also be a useful predictor
of CCA (Saichua et al., 2015) because DNA damage increases the risk of
mutations during cell division that precedes tumour cell formation. NO
may also react with hydrogen peroxide (H2O2) produced by SOD-2, which
is upregulated in PBLs exposed to OV antigen (Yongvanit et al., 2012a,b),
to form peroxynitrite (ONOO), another free radical, thereby further
increasing the risk of DNA damage.
Free radicals might not just be directed towards OV. The liver ﬂuke is
also believed to be a reservoir host for the known carcinogen, H. pylori
(Deenonpoe et al., 2015), which, if it accesses the biliary network, could
exacerbate inﬂammatory responses (Dangtakot et al., 2017) and even pro-
mote carcinogenesis, as it does in gastric cancer (Ajani et al., 2017). Free
radicals may also target invading bacteria in the altered microbiome observed
during opisthorchiasis (Plieskatt et al., 2013; Itthitaetrakool et al., 2016).
This may represent another layer of complexity to OV infection, whereby
immune cell inﬁltration may be in response to bacteria that were once
commensal but have become pathogenic. The alteration of the microbiome
and increases in ﬁbrotic tissue in chronic infection are believed to limit the
contractility of bile ducts. This, in turn, may allow the accumulation of bile
sludge (Mairiang et al., 2012) that may pose an additional threat to the DNA
of local cells.
An increased expression of the antioxidant peroxiredoxin-6 in inﬂam-
matory cells during opisthorchiasis (Khoontawad et al., 2010) indicates the
host’s attempt to protect itself from free radicals generated during infection.
However, upregulation of oxidative enzymes and downregulation of cata-
lase in PBLs may be responsible for the overall accumulation of free radicals
and DNA damage in OV infection. Whilst cells possess DNA repair mech-
anisms that can limit or reverse DNA damage, an increased oxidative envi-
ronment may overwhelm repair mechanisms, especially if OV can alter or
even initiate mutations in these repair mechanisms (Tangkawattana et al.,
2008; Jusakul et al., 2015). It is evident that OV can survive inﬂammatory
responses, although observations following treatment with antiinﬂammatory
drugs suggest the parasite is healthier when inﬂammatory responses are
absent ( Juasook et al., 2012). OV’s ability to survive in this oxidative envi-
ronment may be due to the ability of thioredoxin (Trx), identiﬁed in OV
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cals. This antioxidant may protect OV from oxidative damage. This is an
example of how the parasite has adapted to protect itself from oxidative/
nitrative damage, whilst local cells become damaged and hence are at risk
of initiation of tumourigenesis.
3. HOW DOES OV INFECTION RESULT IN
DEVELOPMENT OF CCA?3.1 CCA: An OV-Induced Wound That Never Heals
Oxidative/nitrative damage is one mechanism by which inﬂamma-
tory responses may directly initiate cancer. However, innate inﬂammatory
responses may indirectly support tumourigenesis by promoting prolifera-
tive responses or inhibiting repair mechanisms during infection. Persistent
OV infection prevents damaged cholangiocytes from fully repairing, which
is a proposed characteristic of tumours (Dvorak, 1986). Usually, inﬂamma-
tory cells leave sites of tissue damage or die by apoptosis once infection is
cleared and then wound healing begins. However, persistent OV infection
may cause inﬂammatory cells to remain throughout the infection (either by
delayed apoptosis or by continuous rounds of inﬁltration), which will
continue to release inﬂammatory and proliferative signals. The antiapop-
totic activity of Trx in the OVES products has been described in cholan-
giocytes exposed to H2O2 in an oxidative stress model (Matchimakul
et al., 2015). In addition to releasing free radicals and phagocytosing debris
and necrotic cells, macrophages recruit ﬁbroblasts via platelet-derived
growth factor (PDGF) and transforming growth factor-beta (TGF-b); iso-
forms of both these cytokines are increased in response to OV infection
(Smout et al., 2009; Boonjaraspinyo et al., 2012). Moreover, it is also
recognized that activated neutrophils can generate locally high levels of
proinﬂammatory and antiinﬂammatory cytokines and chemokines
(Fig. 3), together with a range of growth factors and angiogenic mediators
(Mantovani et al., 2011). High levels of IL-1b signalling (Pinlaor et al.,
2005) from immune cells and increased collagen production and matrix
metalloproteinases (MMPs) from recruited immune cells and ﬁbroblasts
are likely to result in an excess of extracellular matrix (ECM) required for
tissue remodelling (Reviewed in Page-McCaw et al., 2007; Prakobwong
et al., 2009). A role for MMPs in ﬁbrosis-associated CCA in the hamster
model has been proposed (Prakobwong et al., 2010) and MMP/TIMP
Figure 3 Neutrophil activation and generation/release of factors that can promote
autoimmunity, inﬂammation and tissue damage and DNA damage. ROS, reactive
oxygen species.
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2012). This continuous and excessive wound healing is likely to result in
ﬁbrotic tissue developing and promote an overproliferative phenotype in
tissue cells, encouraging cells to replicate repetitively and uncontrollably.
In addition, the proliferative granulin-like protein observed in OV (Smout
et al., 2009) may also assist the wound healing response and tumour
development.
Proliferative and proinﬂammatory cytokines upregulated in opisthorch-
iasis, such as IL-4, IL-6 and TGF-b, are required for wound healing pro-
cesses, such as angiogenesis and cell proliferation. Speciﬁcally, IL-6, which
is implicated in ﬁbrosis and tumourigenesis (Fielding et al., 2014; Naugler
and Karin, 2008), is associated with the development of APF and CCA in
14 Steven W. Edwards et al.
ARTICLE IN PRESSopisthorchiasis (Sripa et al., 2009, 2012b; Frampton et al., 2012). However,
this association is only observed in OV-infected individuals with APF and/
or CCA, not in OV-infected individuals without APF and CCA. This sug-
gests OV may not directly drive this IL-6 production, but APF/CCA may
create the environment responsible for overproduction of IL-6. This impli-
cates IL-6 as an indicator of CCA in OV-infected patients, which may be
used to predict the onset of tumour formation, and this cytokine has previ-
ously been associated with cancers (Chiu et al., 1996; Wehbe et al., 2006).
IL-6 may even increase the number of macrophages at sites of infection,
encouraging further inﬂammatory and proliferative signalling. Inﬂammatory
responses are likely to be responsible for the accumulation of ﬁbrotic tissue,
which can be identiﬁed via ultrasound. Because most OV-infected CCA pa-
tients present with ﬁbrosis before the onset of the cancer, this further impli-
cates inﬂammatory and ﬁbrotic responses in the development of CCA (Sripa
et al., 2012a).
Once a tumour has developed, it requires its own tumour microenviron-
ment (TME) to survive. The TME often constitutes immune cells, ﬁbro-
blasts, blood vessels, inﬂammatory cells, growth factors, and ECM:
however, the TME is only partially deﬁned in OV-induced CCA (Utispan
et al., 2010; Chuaysri et al., 2009). The continued supply of growth factors,
cytokines, nutrients and oxygen and enhanced vascularization during in-
ﬂammatory/proliferative responses towards persistent OV infection are
likely to help tumour progression. One component of the TME is
tumour-associated macrophages (TAMs), which develop the M2 phenotype
via processes that may be promoted by OV. This phenotype is considered
protumourigenic and may support the TME for development of CCA
and may even be implicated in tumour metastasis (Bility and Sripa, 2014).
As the tumour establishes, it is likely to adopt a ‘mutator’ phenotype, char-
acterized by increased genomic instability and erroneous DNA repair. In-
ﬂammatory cell release of free radicals during persistent OV infection may
then allow mutations in DNA to occur more frequently. The chronic
inﬂammation-associated upregulation of proliferative signalling pathways,
phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) and Wnt/b-cat-
enin signalling in OV-induced CCA tissues (Yothaisong et al., 2014) may
support the mutator phenotype, allowing mutated cells to replicate quicker
and more frequently, contributing to the overproliferative and uncontrolled
replication often exhibited in tumours before they metastasize.
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CCA
Whilst it is well established that host inﬂammation contributes to ﬁbrosis and
CCA as a result of OV infection, not every infected individual develops
CCA (Sripa et al., 2012a). Of those infected in Thailand, only w25%
develop advanced periductal ﬁbrosis, and w1%e2% develop CCA
(Mairiang et al., 2012). Whilst these are low percentages, because of the
high number of people infected, this accounts for >26,000 CCA-associated
deaths per year (Sripa and Pairojkul, 2008). The molecular basis for this
heterogenous disease progression following infection is unknown.
Epigenetic alterations in host genomes are capable of causing suscep-
tibility to various cancers and immune disorders and may play a role in
the development of CCA. Whole-exome sequencing of the CCA
genome ( Jusakul et al., 2015) revealed novel gene mutations in CCA
that are involved in chromatin function, including BAP1 (2.8%),
ARID1A (17.6%), MLL3 (13%) and IDH1/2 (2.8%). Decreased expres-
sion and functionality of mismatch repair gene hMLH1 were also
detected in 44.6% of OV-associated CCA ( Jusakul et al., 2015). The
detection of DNA methylation at novel CCA-mutated genes has been
suggested as a biomarker for CCA ( Jusakul et al., 2015). Aberrant
DNA methylation is responsible for changes in cholangiocyte cell fate,
favouring malignancy (Chiang et al., 2015). The identiﬁcation of novel
mutations in the CCA genome could allow for targeted DNA methyl-
ation analysis, using next generation sequencing, enabling rapid diagnosis
of CCA (Masser et al., 2015). In addition, if identiﬁed gene mutations
follow the two-hit or three-hit hypothesis towards CCA development,
individuals at high risk of CCA development could be identiﬁed via
mutated gene alleles (Knudson, 1971; Segditsas et al., 2009). The use
of genome-wide association studies, as used to investigate disorders in
immune function, could be applied to investigate dysregulated immunity
in CCA (Knight, 2013).
However, it is also important to note that where carcinogenesis arises as a
result of viruses, bacteria and other helminths, carcinogenesis usually occurs
following a lifetime of infection allowing genetic alterations to accumulate
over a time, ultimately leading to a malignant phenotype, as opposed to
cancer development in those with a preexisting genetic predisposition
(Smout et al., 2011).
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ARTICLE IN PRESS4. HELICOBACTER: A CANCER-INDUCING BACTERIUM
4.1 Helicobacter and Gastric Disease
Helicobacter spp., especially H. pylori, has long been recognized as a risk
factor for gastroduodenal diseases, including gastritis, peptic ulcer, gastric can-
cer and mucosa-associated lymphoid tissue lymphoma (Moss, 2017; Kao
et al., 2016). Around 50% of the world’s population are infected, and it has
been classiﬁed by the WHO as a type I carcinogen. Most infected
individuals have asymptomatic gastritis, but 10%e20% have an increased
risk of developing peptic ulcers, and 1%e2% infected individuals have an
increased risk of developing distal gastric cancer (Moss, 2017). Infection
with H. pylori occurs in early life, and it may be beneﬁcial in suppressing
asthma, allergies and inﬂammatory bowel disease (Reibman et al., 2008;
Chen and Blaser, 2008; Luther et al., 2010; Koch and Muller, 2015). Host
gene polymorphisms may, at least in part, account for these varied patholog-
ical outcomes following infection. For example, IL-1b polymorphisms result-
ing in enhanced levels of expression of this molecule may predispose to gastric
cancer as this molecule inhibits acid secretion that may lead to gastric atrophy,
metaplasia and then gastric cancer, as well as inducing proliferation of gastric
carcinoma cells (Hwang et al., 2002). IL-1b is therefore one of the key host
factors for H. pylorieassociated gastric cancer progression.
4.2 Helicobacter and Inﬂammation
H. pylori infection is associated with a large inﬁltration of neutrophils
(together with monocytes and some other immune cells), which leads to
gastritis, and there is a strong correlation between bacterial load and neutro-
phil numbers/inﬂammation scores (Xu et al., 2012). Neutrophil inﬂamma-
tion resolves following successful antibiotic treatment. In addition to
neutrophil inﬁltration, there is evidence of neutrophil-mediated ROS pro-
duction and myeloperoxidase release within the gastric epithelium (Davies
et al., 1994; Fu et al., 2016), and these molecules may contribute to the tissue
damage and events associated with the various gastric pathologies, including
gastric cancer.
H. pylori colonization and pathogenicity is dependent on a number of
key genes and proteins. These are (Kao et al., 2016) as follows: (1) urease,
which is responsible for the conversion of urea to ammonia, may help in
generating a localized, nonacidic microenvironment around the bacteria
to promote their survival in the stomach. This enzyme may also affect the
pH of phagosomes following phagocytosis by neutrophils and hence
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the more virulent strains (CagPAI) is a type IV secretory system that effec-
tively delivers CagA protein into host cells to regulate a variety of intracel-
lular signaling systems in the target cells; (3) vacuolating toxin A (VacA)
induces toxicity in epithelial and immune cells; and (4) the bacteria also
express a number of surface adhesion proteins that promote binding to
gastric epithelial cells and they are highly motile.
One of the ﬁrst H. pylori molecules to be characterized was HP-NAP
(neutrophil-activating protein). It was ﬁrst shown that a water-soluble mole-
cule could be isolated fromH. pylori that was capable of activating ROS pro-
duction and chemotaxis in neutrophils (Mooney et al., 1991). This was later
puriﬁed and characterized as HP-NAP, which is a 150-kDa molecule
comprising 10 identical 15-kDa subunits (Evans et al., 1995). The NAP
gene is present in all Helicobacter strains, but there is considerable heteroge-
neity in expression levels between strains. The 3D structure of HP-NAP
resembles that of bacterioferritins (Tsuruta et al., 2012), and it is highly
conserved. HP-NAP is normally present in the bacterial cytosol, and it is
likely released after lysis. It is chemotactic for neutrophils, monocytes and
other immune cells, and in addition to its ability to stimulate ROS and mye-
loperoxidase release from neutrophils (Wang et al., 2008), it can induce the
secretion of a variety of cytokines and chemokines that can play a role in im-
mune activation and pathology. For example, it stimulates the secretion of
TNFa, IL-8, CCL (Chemokine CeC motif ligand) 3, CCL4 from neutro-
phils and IL-6 and other cytokines from monocytes (Alvarez-Arellano et al.,
2007; Amedei et al., 2006). It can also trigger IL-12/23 release from neutro-
phils and monocytes thereby promoting a Th1 response and inhibiting a
Th2 response (D’Elios and Andersen, 2007; de Bernard and D’Elios, 2010).
Other H. pylori molecules that can regulate cytokine/chemokine release
include Hsp (Heat Shock Protein) 60 (GroEL-like HspB) and Hsp10
(GroES-like HspA) that induce IL-8, TNFa and Gro expression via TLR2-
mediated activation of NF-kB (Lin et al., 2009; Zhao et al., 2007). In addition
to stimulating the expression of these proinﬂammatory molecules, the antiin-
ﬂammatory cytokine, IL-10 may also be activated (Pachathundikandi and
Backert, 2018), indicating complex regulatory mechanisms to ﬁne tune the
inﬂammatory process following neutrophil inﬁltration and activation.
4.3 The Inﬂammasome
The inﬂammasome is a multicomponent protein complex that becomes
assembled in innate myeloid cells in response to external signals such as
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cytokines such as IL-1b and IL-18. Inﬂammasome formation (reviewed in
Broz and Dixit, 2016) is often triggered by ligation of PRRs such as
TLRs, C-type lectin receptors (CLRs) or intracellular NOD-like receptors
(NLRs). Their precise structure can vary, but generally they comprise an
NOD-like receptor (e.g., NLRP1, NLRP3 or NLRP4), pro-caspase-1
and apoptosis-associated speck-like protein containing a CARD (cascade
activation and recruitment domain). Once assembled, pro-caspase-1
becomes activated and can cleave pro-IL-1b and pro-IL-18 to active forms,
which, when released, can regulate a number of cell and tissue functions.
Inﬂammasomes containing NLRP3 have been described following expo-
sure of neutrophils or other innate immune cells to H. pylori and its products
(Semper et al., 2014; Perez-Figueroa et al., 2016; Pachathundikandi and
Backert, 2018).
Inﬂammasome formation requires ROS production, potassium efﬂux
and lysosomal destabilization (Semper et al., 2014), and both priming and
second signals are required. The processes by which H. pylori activates the
inﬂammasome in human innate cells are becoming clariﬁed, but there is
some debate in the literature as to the precise mechanisms involved. In
part, these differences may be explained by the different experimental
systems used (e.g., blocking TLR antibodies). A consensus view is emerging
that bacterial components (e.g., LPS, glycopeptides, ﬂagellin, UreB) activate
TLR2 and TLR4, which then result in NF-kB activation. This then acti-
vates transcription of NLPR3 and pro-IL-1b and pro-IL-18, and the
expressed NLPR3 assembles with ASC (apoptosis-associated speck-like pro-
tein containing a CARD) and pro-caspase-1 to form the inﬂammasome.
Activated caspase-1 can then cleave the pro-cytokines that are then released
to activate immune cells and tissue cells. Experiments using H. pylori strains
and mutants with altered expression of key components indicate that the
CagPAI and VacA are required (but perhaps not CagA) for activation of
inﬂammasome assembly in immune cells (Pachathundikandi and Backert,
2018; Semper et al., 2014).
In addition to triggering cytokine expression, ROS production and
degranulation, it was recently shown that human neutrophils adopt a new
phenotype, resembling the N1 phenotype (Whitmore et al., 2017) following
phagocytosis of H. pylori. Following phagocytosis neutrophils become
CD62Ldim, CD11bbright, CD66bbright and CD63bright, in addition generating
proinﬂammatory cytokines. They also have delayed apoptosis and develop
a hypersegmented nucleus (Whitmore et al., 2017). Experiments with
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are not required for the neutrophils to acquire this unusual phenotype that is
sometimes observed in clinical biopsies.
4.4 Helicobacter and Liver Fluke Infections
Helicobacter spp. (including H. pylori, H. hepaticus and H. bilis) are detected in
the bile (Fukuda et al., 2002), gallbladder (Chen et al., 2003) and liver tissue
(Huang et al., 2004) of patients with a number of hepatobiliary diseases. H.
pylori is also detected in patients with liver carcinoma and CCA (Huang
et al., 2004; Pellicano et al., 2004; Xuan et al., 2006; Abu Al-Soud et al.,
2008).
A systematic study of 87 patients with liver ﬂukeeassociated CCA, 53
with cholelithiasis (benign disease group) and healthy control specimens
(from autopsies) identiﬁed H. pylori in 66.7%, 41.5% and 25.0% of
patients in CCA, cholelithiasis and control groups (P < .05), respectively
(Boonyanugomol et al., 2012). H. bilis was detected in 14.9% and 9.4% of
the patients with CCA and cholelithiasis, respectively (P < .05), but this
species was absent from the control group. The cagA gene was detected in
36.2% and 9.1% of patients with CCA and cholelithiasis, respectively
(P < .05, Boonyanugomol et al., 2012).
Further links between H. pylori and OV infection have come from ani-
mal studies. For example, coinfection of Syrian hamsters with OV and H.
pylori resulted in the most severe hepatobiliary abnormalities, including peri-
ductal ﬁbrosis, cholangitis and bile duct hyperplasia and hence a lower
survival rate, compared with animals infected with either pathogen alone
or control groups (Dangtakot et al., 2017). The highest levels of IL-1,
IL-6 and TNFa in liver tissues were also observed in the dual-infected
group. A microbiome/metagenomic study of hamsters infected with OV
identiﬁed several bacterial species in the livers of infected hamsters, including
H. pylori and other Helicobacter spp. (Itthitaetrakool et al., 2016). There are
suggestions that OV may serve as a reservoir for H. pylori (Deenonpoe
et al., 2015), which could explain the presence of this cancer-inducing
bacterium following OV infection. A recent large-scale study of 500 indi-
viduals showed that liver ﬂuke infection was associated with a higher
frequency of CagA-positive H. pylori, present in 64.6% of stool samples
compared with a presence of only 29.6% in stool samples from uninfected
controls (Deenonpoe et al., 2017). The CagPAI is also necessary for bacterial
internalization in primary hepatobiliary cells derived from CCA patients
(Boonyanugomol et al., 2013).
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Link
The recent discovery of a link betweenH. pylori coinfection with OV infec-
tion has a number of implications for understanding disease pathology and
possible new avenues for treatment (Sripa et al., 2017). It is tempting to spec-
ulate that Helicobacter coinfection can stimulate the innate immune system,
by similar mechanisms that occur in gastric disease, to activate the immune
system in opisthorchiasis and contribute to the events that lead to periductal
ﬁbrosis and CCA. H. pyloriederived factors may be responsible for directly
or indirectly activating neutrophils in OV-infected individuals, which may
contribute to the release of tissue-damaging molecules and generation of
proinﬂammatory cytokines and chemokines.
5. CONCLUDING REMARKS AND FUTURE
PERSPECTIVESOV has clear carcinogenic potential. Whether this is a direct result of
promoting overinﬂammatory conditions, overproliferative responses or
decreased repair mechanisms, CCA onset is triggered by OV. The literature
to date indicates that various innate immune responses that are predicted to
occur or have been measured during OV-induced inﬂammation can lead to
cell damage that may initiate or trigger carcinogenesis. Whether OV directly
causes cancer, or whether the hypothesized ‘proinﬂammatory phenotype’ is
directly responsible for the onset of cancer or produces an environment for
cancer to develop from other carcinogens, is still to be determined. Also, it is
necessary to determine the role played by Helicobacter spp. in the events that
lead to the development of CCA. In particular, it is necessary to determine if
this bacterium directly activates the innate immune system in similar ways
that it does in gastric diseases. It would therefore be of interest to determine
if anti-Helicobacter antibiotic treatment will be beneﬁcial in preventing the
development of CCA following OV infection. It is possible that OV has
evolved mechanisms to generate the inﬂammatory environment and cancer
so that it then has access to a greater source of nutrients. However, the
parasite itself is largely resistant to the attempts of the innate immune system
to destroy and eliminate it. More research is required before the proinﬂam-
matory phenotype can be fully characterized. However, if this phenotype
can be demonstrated, it may allow a better understanding of how infectious
agents can drive inﬂammation-related cancer and perhaps other inﬂammatory
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perhaps drawing on analogies in diseases such as rheumatoid arthritis, where
targeting of the immune system with speciﬁc biologic drugs lead to dramatic
improvement in disease progression.REFERENCES
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